Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Study tests non-hallucinogenic analogs of psilocybin and LSD for anti-depressant properties

Staff Writer
Staff Writer 1 year ago
Updated 2022/01/30 at 1:44 AM
Share
SHARE

As psychedelic approaches to treating certain mental illnesses continues to elicit vigorous research, a team of Asian researchers have created non-hallucinogenic analogs of LSD and psilocybin.

The analogs they created could be used as possible treatment for mental illnesses like major depressive disorder and posttraumatic stress disorder (PTSD).

Published in Science, the research team used X-ray crystallography to examine LSD and psilocybin.

“Drugs that target the human serotonin 2A receptor (5-HT2AR) are used to treat neuropsychiatric diseases; however, many have hallucinogenic effects, hampering their use,” the journal report says.


“Here, we present structures of 5-HT2AR complexed with the psychedelic drugs psilocin (the active metabolite of psilocybin) and D-lysergic acid diethylamide (LSD), as well as the endogenous neurotransmitter serotonin and the nonhallucinogenic psychedelic analog lisuride.”

The findings point to the possibility of safe and effective nonhallucinogenic psychedelic analogs with therapeutic effects for the treatment of certain mental illnessses, such as major depressive disorder.

“The 5-HT2AR complex structures presented herein and the resulting insights provide a solid foundation for the structure-based design of safe and effective nonhallucinogenic psychedelic analogs with therapeutic effects,” the report concludes.

Photo: Getty Images

You Might Also Like

Recalling sexual victimization may not be impaired by moderate alcohol intoxication

Research shows obesity-related neurodegeneration is similar to Alzheimer’s disease

New study explores test that can detect Alzheimer’s years before diagnosis

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

TAGGED: LSD, psilocybin, psychedelics
Staff Writer January 29, 2022
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Study explains how alcohol exposure in gestation may raise risk of developmental disorders
Next Article Surveys with nearly identical questions may result in unreliable data

Recommended

Clinical

Recalling sexual victimization may not be impaired by moderate alcohol intoxication

2 Min Read
Clinical

Research shows obesity-related neurodegeneration is similar to Alzheimer’s disease

1 Min Read
Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?